Three patterns of EMA-positive staining were observed. In some cells a "rim" of positive staining was present around the edge of the cells (Fig. 1) . In other cells, a "diffuse" staining of the cytoplasm could be detected (Fig. 2) . The third pattern of staining was characterised by an intense positive staining throughout the cytoplasm (Fig. 3) . Selective EMA staining with this "dense central" pattern is shown in Fig. 4 . The "rim" and "diffuse" staining is described in the Tables as "weak" and was seen on cells which appeared to be either mesothelial or malignant on morphological grounds. The type of cells showing dense central (or "strong") staining could not always be ascertained as the morphological features of the cells were pratially obscured by the stain; but some had clearly visible malignant features. The results of the EMA staining in individual specimens were analysed according to these patterns. Not infrequently more than one type of staining was observed in a smear. Whenever the strong dense central staining was present it was recorded as the pattern of staining for that particular specimen.
The pattern of EMA staining in the 77 effusions from 66 patients with malignant disease of epithelial The remaining three cytologically suspicious effusions showed no EMA staining, and were from patients with cardiac failure.
Discussion
The purpose of our study was to determine the distribution of the epithelial membrane antigen (EMA) in the cells of serous effusions and to establish whether demonstration of the antigen in cytological preparations of effusions was of diagnostic value. Earlier work using tissue sections6 7 had suggested that whereas the majority of carcinomas stain strongly for EMA, particularly when present as single cell infiltrates, normal or reactive mesothelium is either negative or stains weakly and inconsistently.
The results of our investigation showed that 66 of the 77 effusions (86%) from patients with proven epithelial or mesothelial malignancy were found to express the antigen. Of these 66 EMA positive effusions, 25 showed the rim/diffuse type of staining. This weak EMA staining was also observed in nine of the effusions from patients without malignant disease. Since this pattern of staining was present on both carcinoma cells and some mesothelial cells, it cannot be used as a criterion for malignancy. However, the strong dense central staining was found to occur only in effusions where there was either a clinical or a cytological suggestion of malignancy. Forty-two effusions in this study fell into this category. Forty-one of these were from patients with proven malignant disease, and the remaining one was from an 81-year-old woman who presented with pneumonia. Cytological studies showed that this effusion contained very suspicious cells, and a diagnosis of malignancy cannot be ruled out.
Positive EMA staining with the strong dense central pattern may prove to be especially valuable when the cytological diagnosis is uncertain. In this study three of the nine effusions from patients with proven malignant disease, which on cytological evidence were classified as suspicious, showed this strong EMA staining. If subsequent studies confirm that a strong EMA stain is specific for malignancy, not only would this method establish the diagnosis in many cytologically equivocal cases, but would also correct errors of false-negative reporting. This is a relatively insensitive method of diagnosing malignancy, and the lack of specificity of EMA in this study was probably because no suLch grading system was utilised.
There are many other problems of cytological diagnosis in both gynaecological and non-gynaecological practice, for which immunocytochemical staining for epithelial surface antigens may prove useful. We are in the process of investigating the diagnostic potentials of CEA and ZGM in conjunction with EMA on cells in effusions and will be reporting our observations shortly. The methodology for immunocytochemical staining on different types of cytological specimens needs to be developed. Application of EMA staining to the detection of micrometastases in bone marrow has already been investigated.7 11 The application of stains for epithelial antigens to cell suspensions may accelerate the development of automated screening techniques in future, possibly if used in conjunction with a fluorescent second antibody and a suitable flow cytometer.10 EMA staining may have a wide application in diagnostic cytology and further research in this field is indicated.
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